Covered recipient · General Payments record
SANJIV SUR
Allopathic & Osteopathic Physicians Internal Medicine Allergy & Immunology
General Payments · PY2018–2024
$595.18
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $165.88 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.79 | 2 |
| Acerta Pharma LLC | $39.18 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.83 | 1 |
| Grifols USA, LLC | $29.76 | 2 |
| Blueprint Medicines Corporation | $25.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.76 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105405046 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.42 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105672989 | CMS |
| Blueprint Medicines Corporation | $25.32 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147451500 | CMS |
| Grifols USA, LLC | $16.37 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124743974 | CMS |
| Grifols USA, LLC | $13.39 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124743976 | CMS |
| Novartis Pharmaceuticals Corporation | $20.78 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087326821 | CMS |
| Novartis Pharmaceuticals Corporation | $21.01 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087326853 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.83 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137684152 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.